41 related articles for article (PubMed ID: 18632314)
21. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.
Drew DA; Chin SM; Gilpin KK; Parziale M; Pond E; Schuck MM; Stewart K; Flagg M; Rawlings CA; Backman V; Carolan PJ; Chung DC; Colizzo FP; Freedman M; Gala M; Garber JJ; Huttenhower C; Kedrin D; Khalili H; Kwon DS; Markowitz SD; Milne GL; Nishioka NS; Richter JM; Roy HK; Staller K; Wang M; Chan AT
Trials; 2017 Feb; 18(1):50. PubMed ID: 28143522
[TBL] [Abstract][Full Text] [Related]
22. 2-Phenethyl Isothiocyanate, Glutathione S-transferase M1 and T1 Polymorphisms, and Detoxification of Volatile Organic Carcinogens and Toxicants in Tobacco Smoke.
Yuan JM; Murphy SE; Stepanov I; Wang R; Carmella SG; Nelson HH; Hatsukami D; Hecht SS
Cancer Prev Res (Phila); 2016 Jul; 9(7):598-606. PubMed ID: 27099270
[TBL] [Abstract][Full Text] [Related]
23. Factors Associated with Multiple Biomarkers of Systemic Inflammation.
Navarro SL; Kantor ED; Song X; Milne GL; Lampe JW; Kratz M; White E
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):521-31. PubMed ID: 26908433
[TBL] [Abstract][Full Text] [Related]
24. A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoids.
Sterz K; Scherer G; Ecker J
J Lipid Res; 2012 May; 53(5):1026-1036. PubMed ID: 22338011
[TBL] [Abstract][Full Text] [Related]
25. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
Murphey LJ; Williams MK; Sanchez SC; Byrne LM; Csiki I; Oates JA; Johnson DH; Morrow JD
Anal Biochem; 2004 Nov; 334(2):266-75. PubMed ID: 15494133
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of an on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry method for the simultaneous determination of prostaglandins E(2) and F(2alpha) and 13,14-dihydro-15-keto prostaglandin F(2alpha) levels in human plasma.
Komaba J; Matsuda D; Shibakawa K; Nakade S; Hashimoto Y; Miyata Y; Ogawa M
Biomed Chromatogr; 2009 Mar; 23(3):315-23. PubMed ID: 18800333
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of urinary prostaglandin E2 metabolite as a biomarker in infants with fever due to viral infection.
Idborg H; Pawelzik SC; Perez-Manso M; Björk L; Hamrin J; Herlenius E; Jakobsson PJ
Prostaglandins Leukot Essent Fatty Acids; 2014 Dec; 91(6):269-75. PubMed ID: 25305792
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous and high-throughput quantitation of urinary tetranor PGDM and tetranor PGEM by online SPE-LC-MS/MS as inflammatory biomarkers.
Zhang Y; Zhang G; Clarke PA; Huang JT; Takahashi E; Muirhead D; Steenwyk RC; Lin Z
J Mass Spectrom; 2011 Jul; 46(7):705-11. PubMed ID: 21706677
[TBL] [Abstract][Full Text] [Related]
29. Quantification of urinary 8-iso-PGF2alpha using liquid chromatography-tandem mass spectrometry and association with elevated troponin levels.
Saenger AK; Laha TJ; Edenfield MJ; Sadrzadeh SM
Clin Biochem; 2007 Nov; 40(16-17):1297-304. PubMed ID: 17854792
[TBL] [Abstract][Full Text] [Related]
30. Assay of 3-nitrotyrosine in tissues and body fluids by liquid chromatography with tandem mass spectrometric detection.
Rabbani N; Thornalley PJ
Methods Enzymol; 2008; 440():337-59. PubMed ID: 18423229
[TBL] [Abstract][Full Text] [Related]
31. Urinary prostaglandin E2 in the newborn and infant.
Antonucci R; Cuzzolin L; Arceri A; Fanos V
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):1-13. PubMed ID: 17643883
[TBL] [Abstract][Full Text] [Related]
32. Liquid chromatography-tandem mass spectrometric quantification of the dehydration product of tetranor PGE-M, the major urinary metabolite of prostaglandin E(2) in human urine.
Neale JR; Dean BJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):72-7. PubMed ID: 18632314
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
